Innovation Forum Events

Leveraging IP for science start-ups: IMAGINE IF! Workshop with Keltie

Thursday, March 11th 2021

Add to calendar

17:00 – 18:00 (GMT)

Zoom

View map

Do you want to attend? Get your ticket!

Register Now

Description

Intellectual property is the most valuable asset for an early stage scientific start-up. Therefore, it's key to understand its value and how to leverage it in the long term. Join Keltie and the Innovation Forum to discuss strategically leveraging your patents, design rights and other forms of IP in the long term to build revenue streams, collaborations and licensing deals.

This follows on from our Protecting your IP workshop which discusses the early stages of patent searching and protection of multiple forms of IP that can be relevant to your start-up.

Schedule

17:00 - 17:05

Introduction

17:05 - 17:45

Workshop

17:45 - 18:00

Q&A

Speakers

Laura is a Partner in Keltie’s Life Science and Chemistry team. She has a broad academic background in biochemistry and specialises in patent matters relating to biotechnology, precision medicine, immunology, gene therapy, pharmaceuticals, medical devices, stem cells and regenerative medicine, diagnostics, medicinal chemistry, and chemical technology. Laura has a keen interest in precision medicine and medical devices and enjoys working with early stage companies, spinouts and SMEs, and providing strategic and practical advice and support.

David is a Chartered Trade Mark Attorney. He specialises in the prosecution of UK and EU trade marks, trade mark audits, clearance searches and contentious matters such as trade mark opposition proceedings, infringement matters, revocation and invalidity actions. David works with clients large and small across a very broad range of sectors, and particularly enjoys working with start-up clients setting out on their journey.

Sponsors

We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.